Chembio Diagnostics Inc
NASDAQ:CEMI
Chembio Diagnostics Inc
Net Income (Common)
Chembio Diagnostics Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Chembio Diagnostics Inc
NASDAQ:CEMI
|
Net Income (Common)
-$23.3m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
Haemonetics Corp
NYSE:HAE
|
Net Income (Common)
$126.5m
|
CAGR 3-Years
5%
|
CAGR 5-Years
22%
|
CAGR 10-Years
13%
|
|
Cooper Companies Inc
NYSE:COO
|
Net Income (Common)
$290.8m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
0%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Net Income (Common)
-$132m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Align Technology Inc
NASDAQ:ALGN
|
Net Income (Common)
$462.2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
13%
|
See Also
What is Chembio Diagnostics Inc's Net Income (Common)?
Net Income (Common)
-23.3m
USD
Based on the financial report for Dec 31, 2022, Chembio Diagnostics Inc's Net Income (Common) amounts to -23.3m USD.
What is Chembio Diagnostics Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-30%
Over the last year, the Net Income (Common) growth was 31%. The average annual Net Income (Common) growth rates for Chembio Diagnostics Inc have been -19% over the past three years , -30% over the past five years .